An interventional x-ray guidance device approved by the U.S. Food and Drug Administration in 2013 may have the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy for liver cancer.
Researchers have developed a technology that improves the detection of tumors during radiation therapy for early stage lung cancer. It uses standard radiography machines and improves their images through a software approach.
![Rethinking Breast Cancer Screening: Ultra FAST Breast MRI [EDITORIALS]](https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2019/01/d9c87537a9c65b0201218271f730ca51_preview_xlarge_thumbnail_0.jpg)
Breast cancer screening is once again controversial. In this editorial, the author discusses new research demonstrating the effectiveness of an MRI imaging technique called first postcontrast subtracted T1-weighted image (FAST).
Children who undergo repeated complex imaging tests that deliver higher doses of radiation may have a slightly increased lifetime risk of cancer, according to new research.
A multi-institutional, randomized phase III trial of fractionation in locally advanced head and neck cancer demonstrated improved local-regional control and improved overall survival with no increase in late toxicity with hyperfractionated radiation therapy.
Drastic reimbursement cuts for image-guided breast biopsies, and other medical imaging techniques in the 2014 Medicare Fee Schedule Final Rule, may further reduce women’s access to mammography and other breast cancer services.
CR systems are 21 percent less effective at detecting breast cancers than screen-film mammography, but digital direct radiography is found to have similar cancer detection rates.
Low-dose computed tomography (CT) lung screening is more sensitive than radiography, and predictors of cancer on low-dose CT have been identified, according to two studies.
The rate at which women get called back for additional imaging after screening mammography may be higher at hospitals than at community office practices.
Stereotactic body radiotherapy was found to be safe and effective for stage I non-small cell lung cancer, according to a multi-institutional analysis of patterns-of-care and patterns-of-outcome.
